Skip to main content

Full text of "USPTO Patents Application 09804625"

See other formats


IN THE UNITED STATES 
In re Application of: 
WANG et al. 

Application No.: 09/804,625 
Filed: March 9, 2001 
For: BMP PRODUCTS 

Assistant Commissioner for Patents 
Washington, DC 20231 
BOX: PETITIONS 

Sir: 

APPLICATION FOR PATENT TERM ADJUSTMENT UNDER 35 U.S.C. § 1.705 

Applicants have received the Notice of Allowance dated January 24, 2007, 
advising that this application is entitled to thirty-six (36) days of Patent Term 
Adjustment. A copy of this document is enclosed for your reference. Applicants submit 
that the adjustment set forth in the Notice of Allowance is incorrect, and that the correct 
patent term adjustment should be ninety-eight (98) days. Applicants are therefore 
timely filing this Application for Patent Term Adjustment under 37 C.F.R. § 1 .705 before 
payment of the issue fee. 

This application was filed on March 9, 2001. The period for adjustment under 
37 C.F.R. § 703(a)(1) is 340 days, not the 278 days listed on the Patent Term 
Adjustment History provided in PAIR and used to reach the 36 day adjustment term 
calculated by the Patent Office. 



PATENT 

Attorney Docket No. 08702.0039-02000 
PATENT AND TRADEMARK OFFICE 



Group Art Unit: 1647 
Examiner: D. Romeo 
Confirmation No.: 2656 



PATENT 
08702.0039-02000 

STATEMENT OF FACTS 

The error in the patent term adjustment provided with the Notice of Allowance is 
a result of a phantom entry in the PAIR transaction history. The transaction history on 
PAIR shows the issuance of two Requirements for Restriction/Election, one dated 
February 1 1 , 2003 and a second dated April 14, 2003. However, Applicants received 
only one, dated April 14, 2003 and containing an additional cover sheet dated February 
1 1 , 2003. This paper was received by Applicants on April 22, 2003. Applicants note 
that the Restriction Requirement of April 14, 2003 does not reference a prior 
Requirement, confirming that the February 11, 2003 Restriction Requirement was never 
issued. Copies of Transaction History, the Image File Wrapper Index, and the Patent 
Term Adjustment History obtained from PAIR, along with the April 14, 2003 Restriction 
Requirement are attached. 

When the Office calculated the patent term adjustment available under 
37 C.F.R. § 1.703(a)(1) (the number of days in the period beginning on the day after the 
date that is 14 months from the application filing date), the February 11, 2003 date was 
used as the mailing date of the first action under 35 U.S.C. § 132. This resulted in a 37 
C.F.R. § 1 .703(a)(1) adjustment of 278 days. Applicants submit that this calculation is 
incorrect because the February 11, 2003 Restriction Requirement was never mailed, as 
evidenced by its absence in the Patent Office's or Applicants' files anywhere other than 
as an extra cover sheet in the Restriction Requirement of April 14, 2003. Applicants 
submit that the first action under 35 U.S.C. § 132 was mailed on April 14, 2003. Using 
the April 14, 2003 Restriction Requirement as the first action under 35 U.S.C. 132, the 
adjustment period under 7 C.F.R. § 1.703(a)(1) is 340 days. 



-2- 



PATENT 
08702.0039-02000 



TERMINAL DISCLAIMER AND EXPIRATION DATE 

Applicants note that this application is subject to a terminal disclaimer over U.S. 
Patent No. 5,166,058, which will expire on November 24, 2009. Without patent term 
adjustment, any patent granted off the instant application would expire on April 8, 2008, 
and with the requested 98 days of term adjustment, it would expire on July 15, 2008. 
Therefore, the terminal disclaimer over U.S. Patent No. 5,166,058 will not affect the 
expiration date of a patent granted off the instant application. 

CONCLUSION 

In light of the facts set forth above, Applicants request that this patent expiration 
date be adjusted by 98 days to accurately reflect the delay on the part of the Office. 
Applicants enclose $200.00 to cover the fee set forth in 37 C.F.R. § 1.18(e) for filing this 
request. Please charge any deficiencies to our Deposit Account No. 06-0916. If there 
are any other fees due in connection with the filing of this request, please also charge 
such fees to our Deposit Account No. 06-0916. 



Attachments: 

• Notice of Allowance 

• Transaction History (PAIR 03/05/07) 

• Image File Wrapper Index (PAIR 03/05/07) 

• Restriction Requirement of 04/14/03 (PAIR 03/05/07) 



Respectfully submitted, 



FINNEGAN, HENDERSON, FARABOW, 
GARRETT & DUNNER, L.L.P. 



Dated: March 12, 2007 




Elizabeth E. Mathiesen 
Reg. No. 54,696 



-3- 



JSJt 

w 



United States Patent and Trademark Office 



UNITED STATES DEPARTMENT OF COMMERCE' 
United States Patent and Trademark Office 
Address: COMMISSIONER FOR PATENTS 



NOTICE OF ALLOWANCE AND FEE(S) DUE 



22852 7590 01/24/2007 I 

FINNEGAN, HENDERSON, FARABOW, GARRETT & DUNNER ( romeqdavids 



LLP ART UNIT J PAPER NUMBER 

90 1 NEW YORK AVENUE, N W 1 — 1 

WASHINGTON, DC 20001-4413 DATE MAILED: 0./24/2007 



APPLICATION NO. I FILING DATE I FIRST NAMED INVENTOR I ATTORNEY DOCKET NO. I CONFIRMATION N 



09/804,625 03/09/2001 
TITLE OF INVENTION: NOVEL BMP PRODUCTS 



j APPLN. TYPE | SMALL ENTITY | ISSUE FEE DUE j PUBLICATION FEE DUE j PREV. PAID ISSUE FEE J TOTAL FEE(S) DUE | DATE DUE | 
nonprovisional NO SI 400 $300 $0 $1700 04/24/2007 

THE APPLICATION IDENTIFIED ABOVE HAS BEEN EXAMINED AND IS ALLOWED FOR ISSUANCE AS A PATENT. 
PROSECUTION ON THE MERITS IS. CLOSED. THIS NOTICE OF ALLOWANCE IS NOT A GRANT OF PATENT RIGHTS. 
THIS APPLICATION IS SUBJECT TO WITHDRAWAL FROM ISSUE AT THE INITIATIVE OF THE OFFICE OR UPON 
PETITION BY THE APPLICANT. SEE 37 CFR 1 313 AND MPEP 1308. 

THE ISSUE FEE AND PUBLICATION FEE (IF REQUIRED) MUST BE PAH) WITHIN THREE MONTHS FROM THE 
MAILING DATE OF THIS NOTICE OR THIS APPLICATION SHALL BE REGARDED AS ABANDONED. THIS 
STATUTORY PERIOD CANNOT BJ£ EXTENDED. SEE 35 U.S.C. 151. THE ISSUE FEE DUE INDICATED ABOVE DOES 
NOT REFLECT A CREDIT FOR ANY PREVIOUSLY PAID ISSUE FEE IN THIS APPLICATION. IF AN ISSUE FEE HAS 
PREVIOUSLY BEEN PAID IN THIS APPLICATION (AS SHOWN ABOVE), THE RETURN OF PART B OF THIS FORM 
WILL BE CONSIDERED A REQUEST TO REAPPLY THE PREVIOUSLY PAH) ISSUE FEE TOWARD THE ISSUE FEE NOW 
DUE. 



HOW TO REPLY TO THIS NOTICE: 



I. Review the SMALL ENTITY status shown above. 

If the SMALL ENTITY is shown as YES, verify your current 
SMALL ENTITY status: 

A. If the status is the same, pay the TOTAL FEE(S) DUE shown 
above. 

B. If the status above is to be removed, check box 5b on Part B - 
Fee(s) Transmittal and pay the PUBLICATION FEE (if required) 
and twice the amount of the ISSUE FEE shown above, or 



If the SMALL ENTITY is shown as NO: 



A. Pay TOTAL FEE(S) DUE shown above, or 



B. If applicant claimed SMALL ENTITY status before, or is now 
claiming SMALL ENTITY status, check box 5a on Part B - Fee(s) 
Transmittal and pay the PUBLICATION FEE (if required) and 1/2 
the ISSUE FEE shown above. 



II. PART B - FEE(S) TRANSMITTAL, or its equivalent, must be completed and returned to the United States Patent and Trademark Office 
(USPTO) with your ISSUE FEE and PUBLICATION FEE (if required). If you are charging the fee(s) to your deposit account, section "4b" 
of Part B - Fee(s) Transmittal should be completed and an extra copy of the form should be submitted. If an equivalent of Part B is filed, a 
request to reapply a previously paid issue fee must be clearly made, and delays in processing may occur due to the difficulty in recognizing 
the paper as an equivalent of Part B. 

III. All communications regarding this application must give the application number. Please direct all communications prior to issuance to 
Mail Stop ISSUE FEE unless advised to the contrary. 

IMPORTANT REMINDER: Utility patents issuing on applications filed on or after Dec. 12, 1980 may require payment of 
maintenance fees. It is patentee's responsibility to ensure timely payment of maintenance fees when due. 



PTOL-85 (Rev. 07/06) Approved for use through 04/30/2007. 



Page 1 of 3 



PART B - FEE(S) TRANSMITTAL 

Complete and send this form, together with applicable fee(s), to: Mail Mail Stop ISSUE FEE 

Commissioner for Patents 
P.O. Box 1450 

Alexandria, Virginia 22313-1450 
or Fax (571)-273-2885 

INSTRUCTIONS: This form should be used for transmitting the ISSUE FEE and PUBLICATION FEE (if required). Blocks 1 through 5 should be completed where 
appropriate. All further correspondence including the Patent, advance orders and notification of maintenance fees will be mailed to the current corresjpondence address as 
indicated unless corrected below or directed otherwise in Block 1 , by (a) specifying a new correspondence address; and/or (b) indicating a separate "FEE ADDRESS" for 
maintenance fee notifications. 

current correspondence address (Note: u« Block i for any change of address) Note: A certificate of mailing can only be used tor domestic mailings of the 

Fee(s) Transmittal. This certificate cannot be used for any other accompanying 
papers. Each additional paper, such as an assignment or formal drawing, must 
nave its own certificate of mailing or transmission. 

22852 7590 01/24/2007 

Certificate of Mailing or Transmission 

FINNEGAN, HENDERSON, FARABOW, GARRETT & DUNNErWby certify that this Fee® Transmittal is being deposited with the United 
j^j^p "^i 1 * 3 *°j Sta ' Service with sufficient postage Jor first class mail in an envelope 

901 NEW YORK AVENUE, NW 



WASHINGTON, DC 20001-4413 




(Depositor's name) 






(Signature) 






(Dale) 


j APPLICATION NO. | FILING DATE | 


FIRST NAMED INVENTOR 


| ATTORNEY DOCKET NO. | CONFIRMATION NO. 



09/804,625 03/09/2001 
TITLE OF INVENTION: NOVEL BMP PRODUCTS 



APPLN. TYPE 



SMALL ENTITY 



PUBLICATION FEE DUE PREV. PAID ISSUE FEE | TOTAL FEE(S) DI 



CLASS-SUBCLASS 



ROMEO, DAVID S 



2. For printing on the patent front page, list 

(1) the names of up to 3 registered patent attorneys 
or agents OR, alternatively, 

(2) the name of a single firm (having as a member a 
registered attorney or agent) and the names of up to 
2 registered patent attorneys or agents. If no name is 
listed, no name will be printed. 



;e address or indication of "Fee Address" (37 

Q Change of correspondence address (or Change of Correspondence 
Address form PTO/SB/122) attached. 

Q "Fee Address" indication (or "Fee Address" Indication form 
PTO/SB/47; Rev 03-02 or more recent) attached. Use of a Customer 
Number is required. 



3. ASSIGNEE NAME AND RESIDENCE DATA TO BE PRINTED ON THE PATENT (print or type) 



(A) NAME OF ASSIGNEE 



is identified below, the document has been filed for 
(B) RESIDENCE: (CITY and STATE OR COUNTRY) 



Please check the appropriate assignee category or categories (will not be printed on the patent) : Q Individual Q Corporation or other private group entity Q Government 



4a. The following fee(s) are submitted: 
Q Issue Fee 

Q Publication Fee (No small entity discount permitted) 
Q Advance Order - # of Copies 



4b. Payment of Fee(s): (Please first reapply any previously paid issue fee shown above) 

Q A check is enclosed. 

O Payment by credit card. Form PTO-2038 is attached. 

QThe Director is hereby authorized to charge the required feefs), any deficiency, or credit any 
i-> . . i (enclose an extra copy of this form 



overpayment, to Deposit Account Number _ 



5. Change in Entity Status (from status indicated above) 

□ a. Applicant claims SMALL ENTITY status. See 37 CFR 1.27. □ b. Applicant is n 


o longer claiming SMALL ENTITY status. See 37 CFR 1 .27(g)(2). 


NOTE: The Issue Fee and Publication Fee (if required) will not be accepted from anyone other t 
interest as shown by the records of the United States Patent and Trademark Office. 


nan the applicant; a registered attorney or agent; or the assignee or other party in 


Authorized Signature 


Date 


Typed or printed name 


Registration No. 





submitting the completed application form to the USPTO. Time will vary depending upon the individual case. Any comments on the* amount of time*you req"uii . 

this form and/or suggestions for reducing this burden, should be sent to the Chieflnformation Officer, U.S. Patent and Trademark Office, U.S. Department of Commerce, P.O. 
Box 1450, Alexandria, Virginia 22313-1450. DO NOT SEND FEES OR COMPLETED FORMS TO THIS ADDRESS. SEND TO: Commissioner for Patents, P.O. Box 1450, 
Alexandria, Virginia 22313-1450. 

Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it displays a valid OMB control number. 



PTOL-85 (Rev. 07/06) Approved for use through 04/30/2007. 



OMB 0651-0033 U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE 



09/804,625 03/09/2001 



Elizabeth A. Wang 



5160C-CON 



2656 



22852 7590 01/24/2007 |_ 

FINNEG AN, HENDERSON, FARABOW, GARRETT & DUNNER R0ME0, DAVID s 



LLP I ART UNIT j PAPER NUMBER 

90 1 NEW YORK AVENUE, N W ~ 

WASHINGTON, DC 20001-4413 DATE MAILED: 01/24/2007 



Determination of Patent Term Adjustment under 35 U.S.C. 154 (b) 

(application filed on or after May 29, 2000) 

The Patent Term Adjustment to date is 36 day(s). If the issue fee is paid on the date that is three months after the 
mailing date of this notice and the patent issues on the Tuesday before the date that is 28 weeks (six and a half 
months) after the mailing date of this notice, the Patent Term Adjustment will be 36 day(s). 

If a Continued Prosecution Application (CPA) was filed in the above-identified application, the filing date that 
determines Patent Term Adjustment is the filing date of the most recent CPA. 

Applicant will be able to obtain more detailed information by accessing the Patent Application Information Retrieval 
(PAIR) WEB site (http://pair.uspto.gov). 

Any questions regarding the Patent Term Extension or Adjustment determination should be directed to the Office of 
Patent Legal Administration at (571)-272-7702. Questions relating to issue and publication fee payments should be 
directed to the Customer Service Center of the Office of Patent Publication at l-(888)-786-0101 or 
(571)-272-4200. 



PTOL-85 (Rev. 07/06) Approved for use through 04/30/2007. 



Page 3 of 3 



United States Patent & Trademark Office 



Page 1 of 2 




https://sportal.uspto.gOv/secure/myportal/lut/p/kcxml/04_Sj9SPykssy0xPLMnMz0vM0Y_... 3/5/2007 



United States Patent & Trademark Office 



Page 2 of 2 




https://sportal.uspto.gOv/secure/myportal/Iut/p/kcxml/04_Sj9SPykssy0xPLMnMz0vM0Y__... 3/5/2007 



Page 1 of 8 




https://sportal.uspto.gOv/secure/myportal/Iut/p/kcxml/04_Sj9SPykssy0xPLMnMz0vM0Y_... 3/5/2007 



United States Patent & Trademark Office 



Page 2 of 8 




https://sportal.uspto.gOv/secure/myportal/lut/p/kcxml/04_Sj9SPykssy0xPLMnMz0vM0Y_. . . 3/5/2007 



United States Patent & Trademark Office 



Page 3 of 8 




https://sportal.uspto.gOv/secure/myportal/lut/p/kcxml/04_Sj9SPykssy0xPLMriMz0vM 



3/5/2007 



United States Patent & Trademark Office 



Page 4 of 8 




https://sportal.uspto.gOv/secure/myportal/iut/p/kcxml/04_Sj9SPykssy0xPLMnMz0vM0Y_ 



3/5/2007 



United States Patent & Trademark Office 



Page 5 of 8 




https://sportal.uspto.gOv/secure/myportal/Iut/p/kcxml/04_Sj9SPykssy0xPLMnMz0vM0Y_... 3/5/2007 



United States Patent & Trademark Office 



Page 6 of 8 




https://sportal.uspto.gOv/secure/myportal/Sut/p/kcxml/04_Sj9SPykssy0xPLMnMz0vM0Y_... 3/5/2007 



United States Patent & Trademark Office 



Page 7 of 8 




https://sportal.uspto.gOv/secure/myportal/Iut/p/kcxml/04_Sj9SPykssy0xPLMnMz0vM0Y_... 3/5/2007 



United States Patent & Trademark Office 



Page 8 of: 




https://sportal.uspto.gOv/secure/myportal/Sut/p/kcxml/04_Sj9SPykssy0xPLMnMz0vM0Y_ 



3/5/2007 



United States Patent & Trademark Office 



Page 1 of 2 




https://sportal.uspto.gov/secure/myportal/!ut/p/kcxml/04^Sj9SPykssy0xPLMnMz0vM0Y_... 3/5/2007 



United States Patent & Trademark Office 



Page 2 of 2 




https://sportal.uspto.gOv/secure/myportal/lut/p/kcxml/04_Sj9SPykssy0xPLMnMz0vM0Y_... 3/5/2007 



United States Bvtent and Trademark Office 



| ATTORNEY DOCKET NO. | CONFIRMATIONS 



APPLICATION NO. 



FILING DATE 



FIRST NAMED INVENTOR 



FINNEGAN, HENDERSON, FARAJBOW 
GARRETT AND DUNNER, LLP 
1300 1 STREET, N.W. 
WASHINGTON, DC 20005-3315 



ROMEO, DAVID S 



PAPER NUMBER 



DATE MAILED: 04/14/2003 



Please find below and/or attached an Office communication concerning this application or proceeding. 




FINNEGAN, HENDERSON, FARABOW 
GARRETT AND DUNNER, LLP ' 



Docketed <x»-'2x-o^ Attorne y i-Ar-Jg~e *«i 
Case <yg>Q-Z- gb^o, -kSZ, 
Due Date Or-TcT - o =1 u)| t^f 
Action "Dug" 



PTO-90C (Rev. 07-01) 




;Jff: : \ United States Bvtent and Trademark Qfi 



APPLICATION NO. 



FIRST NAMED IN 



Elizabeth A. Wang 



7590 02/1 1/2003 

American Home Products Corporation 
Attention: Kay E. Brady 
Patent & Trademark Office - 2B 
One Campus Drive 
Parsippany, NJ 07054 



ROMEO, DAVID S 



PAPER NUMBER 



DATE MAILED: 02/1 1/2003 



Please find below and/or attached an Office communication concerning this application or proceeding. 



PTO-90C (Rev. 07-01) 



bffice Action Summary 



Application No. Applicant(s) 



09/804,625 



Examiner 

David S Romeo 



WANG ETAL. 



Art Unit 

1647 



- The MAILING DATE of this communication appears on the cover sheet with the correspondence address - 
Period for Reply 

A SHORTENED STATUTORY PERIOD FOR REPLY IS SET TO EXPIRE 1 MONTH(S) FROM 
THE MAILING DATE OF THIS COMMUNICATION. 

- Extensions of time may be available under the provisions of 37 CFR 1.136(a). In no event, however, may a reply be timely filed 
after SIX (6) MONTHS from the mailing date of this communication. 

- If the period for reply specified above is less than thirty (30) days, a reply within the statutory minimum of thirty (30) days will be considered timely. 

- If NO period for reply is specified above, the maximum statutory period will apply and will expire SIX (6) MONTHS from the mailing date of this communication. 

- Failure to reply within the set or extended period for reply will, by statute, cause the application to become ABANDONED (35 U.S.C. § 133). 

- Any reply received by the Office later than three months after the mailing date of this communication, even if timely filed, may reduce any 
earned patent term adjustment. See 37 CFR 1 .704(b). 

Status 

1)13 Responsive to communication(s) filed on 29 March 2001 . 
2a)D This action is FINAL. 2b)03 This action is non-final. 

3) D Since this application is in condition for allowance except for formal matters, prosecution as to the merits is 
closed in accordance with the practice under Ex parte Quayle, 1935 CD. 11, 453 O.G. 213. 

Disposition of Claims 

4) I3 Claim(s) 24-49 is/are pending in the application. 

4a) Of the above claim(s) is/are withdrawn from consideration. 

5) D Claim(s) is/are allowed. 

6) D Claim(s) is/are rejected. 

7) D Claim(s) is/are objected to. 

8) 03 Claim(s) 24-49 are subject to restriction and/or election requirement. 
Application Papers 

9) D The specification is objected to by the Examiner. 

10) D The drawing(s) filed on is/are: a)Q accepted or b)D objected to by the Examiner. 

Applicant may not request that any objection to the drawing(s) be held in abeyance. See 37 CFR 1.85(a). 

1 1) D The proposed drawing correction filed on is: a)D approved b)D disapproved by the Examiner. 

If approved, corrected drawings are required in reply to this Office action. 

12) D The oath or declaration is objected to by the Examiner. 
Priority under 35 U.S.C. §§119 and 120 

1 3) D Acknowledgment is made of a claim for foreign priority under 35 U.S.C. § 1 1 9(a)-(d) or (f). 

a)dAII b)D Some*c)D None of: 

1 .□ Certified copies of the priority documents have been received. 

2. D Certified copies of the priority documents have been received in Application No. . 

3. D Copies of the certified copies of the priority documents have been received in this National Stage 

application from the International Bureau (PCT Rule 17.2(a)). 
* See the attached detailed Office action for a list of the certified copies not received. 

14) D Acknowledgment is made of a claim for domestic priority under 35 U.S.C. § 1 1 9(e) (to a provisional application). 

a) □ The translation of the foreign language provisional application has been received. 

15) D Acknowledgment is made of a claim for domestic priority under 35 U.S.C. §§ 120 and/or 121 . 

Attachment(s) 

1 ) O Notice of References Cited (PTO-892) 4) □ Interview Summary (PTO-41 3) Paper No(s). . 

2) EH Notice of Draftsperson's Patent Drawing Review (PTO-948) 5) CH Notice of Informal Patent Application (PTO-1 52) 

3) O Information Disclosure Statement(s) (PTO-1449) Paper No(s) ___ . 6) □ Other: 

PTO-326 (Rev. 04-01 ) Office Action Summary Part of Paper No. 8 



Applitation/Control Number: 09/804,625 Page 2 

Art Unit: 1647 

DETAILED ACTION 

The preliminary amendment mailed March 9, 2001 (Paper No. 6) has been entered. 

The numbering of claims is not in accordance with 37 CFR 1 . 126 which requires the 
original numbering of the claims to be preserved throughout the prosecution. When claims are 
canceled, the remaining claims must not be renumbered. When new claims are presented, they 
must be numbered consecutively beginning with the number next following the highest 
numbered claims previously presented (whether entered or not). 

Misnumbered claims 47-50 have been renumbered 46-49, respectively. 

Claims 24-49 are pending. 

Election/Restrictions 

Restriction to one of the following inventions is required under 35 U.S. C. 121: 

I. Claims 24-26, 29, 30, 33, 35, 36, 38, 39, 41, 42, to the extent that they are drawn 
to a polynucleotide encoding amino acids 299-396 of Figure 2, classified in class 
536, subclass 23.5. 

II. Claims 24, 27, 28, 3 1, 32, 34, 35, 37, 38, 40, 41, 43, to the extent that they are 
drawn to a polynucleotide encoding amino acids 3 1 1-408 of Figure 3, classified in 
class 536, subclass 23.5. 

III. Claims 44-48, drawn to a polypeptide comprising amino acids 299-396 of Figure 
2, classified in class 530, subclass 300. 



Applitation/Control Number: 09/804,625 Page 3 

Art Unit: 1647 

IV. Claim 49, drawn to an antibody that binds a polypeptide comprising amino acids 
299-396 of Figure 2, classified in class 530, subclass 387.1. 
The inventions are distinct, each from the other because of the following reasons: 

The following pairwise combinations of products are independent and distinct, wherein 
neither member of a pair is required for the production or use of the other, and wherein each of 
the pair can be manufactured independently of the other and/or used for independent and distinct 
purposes: I and II; II and each of III and IV. 

The polynucleotides of Invention I are related to the polypeptides of Invention III by 
virtue of encoding same. The polynucleotide has utility for the recombinant production of the 
polypeptide in a host cell. Although the polynucleotide and polypeptide are related since the 
polynucleotide encodes the specifically claimed polypeptide, they are distinct inventions because 
they are physically and functionally distinct chemical entities, and the polypeptide product can 
be made by another and materially different process, such as by synthetic polypeptide synthesis 
or purification form the natural source. Further, the polynucleotide may be used for processes 
other than the production of the polypeptide, such as a nucleic acid hybridization assay. 

The polynucleotide of invention I and the antibody of Invention IV are related by virtue 
of the polypeptide that is encoded by the polynucleotide and necessary for the production of the 
antibody. However, the polynucleotide itself is not necessary for antibody production and both 
are wholly different compounds having different compositions and functions. Therefore, these 
inventions are distinct. 

The polypeptide of invention III is related to the antibody of Invention IV by virtue of 
being the cognate antigen, necessary for the production of the antibody. Although the 



Application/Control Number: 09/804,625 Page 4 

Art Unit: 1647 

polypeptide and antibody are related due to the necessary stearic complementarity of the two, 
they are distinct inventions because they are physically and functionally distinct chemical 
entities, and because the polypeptide can be used in another materially different process from the 
use for production of the antibody, such as in a pharmaceutical composition in its own right, or 
5 in assays for the identification of agonists or antagonists. 

Because these inventions are distinct for the reasons given above and have acquired a 
separate status in the art as shown by their different classification, restriction for examination 
purposes as indicated is proper. 

Because these inventions are distinct for the reasons given above and the searches 
10 required are not coextensive, restriction for examination purposes as indicated is proper. 

Because these inventions are distinct for the reasons given above and have acquired a 
separate status in the art because of their recognized divergent subject matter, restriction for 
examination purposes as indicated is proper. 

Applicant is advised that the reply to this requirement to be complete must include an 
1 5 election of the invention to be examined even though the requirement be traversed (37 CFR 
1.143). 

Applicant is reminded that upon the cancellation of claims to a non-elected invention, the 
inventorship must be amended in compliance with 37 CFR 1 .48(b) if one or more of the 
currently named inventors is no longer an inventor of at least one claim remaining in the 
20 application. Any amendment of inventorship must be accompanied by a request under 37 CFR 
1 .48(b) and by the fee required under 37 CFR 1 . 17(i). 

Any inquiry concerning this communication or earlier communications from the examiner should be directed to 
David S. Romeo whose telephone number is (703) 305-4050. The examiner can normally be reached on Monday through 
Friday from 7:30 a.m. to 4:00 p.m. 



Application/Control Number: 09/804,625 
"Art Unit: 1647 



Page 5 



If attempts to reach the examiner by telephone are unsuccessful, the examiner's supervisor, Gary Kunz, can be 

REACHED ON (703) 308-4623. 

IF SUBMITTING OFFICIAL CORRESPONDENCE BY FAX, APPLICANTS ARE ENCOURAGED TO SUBMIT OFFICIAL CORRESPONDENCE TO 
THE FOLLOWING TC 1600 BEFORE AND AFTER FINAL RiGHTFAX NUMBERS: 

Before Final (703) 872-9306 
After Final (703) 872-9307 

in addition to the official rightfax numbers above, the tc 1 600 fax center has the following official fax 

NUMBERS: (703) 305-3592, (703) 308-4242 AND (703) 305-3014. 

Customers are also advised to use Certificate of Facsimile procedures when submitting a reply to a non-final 
or final Office action by facsimile (see 37 CFR 1 .6 and 1 .8). 

Faxed draft or informal communications should be directed to the examiner at (703) 308-0294. 

Any inquiry of a general nature or relating to the status of this application or proceeding should be directed 
to the Group receptionist whose telephone number is (703) 308-0196. 




David Romeo 
Primary Examiner 
Art Unit 1647 



DSR 



February 10, 2003